noscript

News and Announcements

Analytica Ltd released the first production of PeriCoach Version 3

  • Published May 01, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Analytica Ltd (ASX: ALT) has today released the first production units of the next generation Version 3 PeriCoach® device. The device is an integral part of the PeriCoach system which includes a smartphone app and data management system.

KEY TAKEAWAYS:

  • The version 3 device implements significant improvements in processing capability, wireless connectivity and power management, over-the-air firmware update capability, as well as enhanced user experience.
  • An important advance for the v3 device is the inclusion of an accelerometer and gyroscope ‘chip’ also found in mobile phones and other wearable technology.
    • This component allows the system to sense the motion of the device during a pelvic floor exercise session.
  • The new v3 hardware, combined with the force sensors that directly measure pelvic floor muscle squeeze force, will allow the system to make an assessment about exercise technique by comparing the sensor signals against a database of correct and incorrect technique signatures.

Analytica CEO Geoff Daly said: “We’re very excited about the release of v3. Externally the v3 does not look much different but inside it’s got some great new technology. Key opinion leaders have told us from this product’s inception that correct technique is critical to the efficacy of pelvic floor exercise. Their message is that poor technique leads to poor results, and that causes women to simply give up. When half of all women don’t do their exercises correctly to start with, the dropout rate has a big impact on clinician’s faith in pelvic floor exercise and many time-poor clinicians simply hand their patients a pamphlet.”

“The v3 has the potential to break this circle, helping more women to do their exercises correctly, getting better outcomes, and restoring conservative treatments as the first step before jumping to surgery.”

“Advancing the hardware lays the foundation. Expect to see further developments in software and functionality this quarter as we analyse anonymised v3 real-world data and develop the treatment algorithms. Real-world patient data will provide insights into clinical practice, guide improvements for product development, and deliver evidence of the product’s efficacy for women, clinicians, and potential licensees.”

“There are a lot of toys making noise in the market. PeriCoach is the only serious medical device using evidence to target this enormous and mostly hidden issue of pelvic floor health.”

Analytica’s lead product is the PeriCoach® System – an e-health treatment system for women who suffer Stress Urinary Incontinence. This affects 1 in 3 women worldwide and is mostly caused by trauma to the pelvic floor muscles as a result of pregnancy, childbirth and menopause.

PeriCoach comprises a device, web portal and smartphone app. The device evaluates activity in pelvic floor muscles. This information is transmitted to a smartphone app and can be loaded to a cloud database where physicians can monitor patient progress via web portal.

Request Information

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now